Back to All Events

Workshop on Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies


The workshop is co-hosted by The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration (FDA).

SCB’s Kelly Sauerwein and Katie Zander will be attending.

LEARN MORE